Stonebridge Capital Management Inc. Sells 300 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Stonebridge Capital Management Inc. cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 0.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 76,809 shares of the medical instruments supplier’s stock after selling 300 shares during the quarter. DENTSPLY SIRONA accounts for about 1.9% of Stonebridge Capital Management Inc.’s holdings, making the stock its 19th biggest holding. Stonebridge Capital Management Inc.’s holdings in DENTSPLY SIRONA were worth $4,901,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently made changes to their positions in the company. Montag A & Associates Inc. bought a new stake in DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. Patriot Financial Group Insurance Agency LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $33,000. Berman Capital Advisors LLC lifted its holdings in shares of DENTSPLY SIRONA by 64.2% in the 4th quarter. Berman Capital Advisors LLC now owns 655 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 256 shares during the last quarter. RPG Investment Advisory LLC bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $37,000. Finally, CI Investments Inc. raised its holdings in DENTSPLY SIRONA by 34.5% during the 4th quarter. CI Investments Inc. now owns 718 shares of the medical instruments supplier’s stock valued at $38,000 after buying an additional 184 shares during the last quarter. Institutional investors and hedge funds own 96.00% of the company’s stock.

Shares of NASDAQ:XRAY traded down $0.80 during midday trading on Thursday, reaching $63.14. The company’s stock had a trading volume of 24,660 shares, compared to its average volume of 1,640,007. The firm has a 50 day moving average of $59.65 and a 200-day moving average of $53.26. The firm has a market capitalization of $13.83 billion, a P/E ratio of -278.00, a PEG ratio of 5.06 and a beta of 0.98. The company has a quick ratio of 2.38, a current ratio of 3.10 and a debt-to-equity ratio of 0.47. DENTSPLY SIRONA Inc. has a 12-month low of $36.12 and a 12-month high of $65.09.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Sunday, February 28th. The medical instruments supplier reported $0.87 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.23. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $997.38 million. DENTSPLY SIRONA had a negative net margin of 1.40% and a positive return on equity of 7.13%. The company’s revenue was down 2.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.73 EPS. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 1.12 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, April 9th. Investors of record on Friday, March 26th will be paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date of this dividend is Thursday, March 25th. DENTSPLY SIRONA’s payout ratio is 16.33%.

A number of equities research analysts recently commented on XRAY shares. HC Wainwright reiterated a “neutral” rating and set a $60.00 price target (up from $55.00) on shares of DENTSPLY SIRONA in a report on Tuesday, March 2nd. Stifel Nicolaus lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and set a $52.00 price target for the company. in a report on Friday, December 18th. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $71.00 price target for the company in a report on Monday, March 8th. Piper Sandler upped their price target on shares of DENTSPLY SIRONA from $63.00 to $70.00 and gave the company an “overweight” rating in a report on Monday, March 1st. Finally, Barclays upped their price target on shares of DENTSPLY SIRONA from $50.00 to $55.00 and gave the company an “underweight” rating in a report on Tuesday, March 2nd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $54.69.

In related news, Director Eric Brandt sold 7,600 shares of the company’s stock in a transaction dated Wednesday, March 17th. The shares were sold at an average price of $63.21, for a total value of $480,396.00. Following the transaction, the director now owns 38,131 shares in the company, valued at approximately $2,410,260.51. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Gregory T. Lucier purchased 5,000 shares of the company’s stock in a transaction that occurred on Thursday, March 4th. The stock was purchased at an average price of $58.95 per share, for a total transaction of $294,750.00. Following the purchase, the director now owns 13,850 shares in the company, valued at $816,457.50. The disclosure for this purchase can be found here. Insiders own 0.53% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Read More: What is a Reverse Stock Split?

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.